Uncategorized
Aerie Pharmaceuticals to Participate in the H.C. Wainwright Ophthalmology Conference
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced that Casey C. Kopczynski, Ph.D., Chief Scientific Officer, will participate in a virtual panel discussion titled, “What are the Greatest Unmet Needs Facing Ophthalmology Today?”, at